Since its inception, the Division of Clinical Research has had a simple and constant mission: To increase the quality, quantity and efficiency of translating fundamental science advances into improved clinical care for our patients.

The Division of Clinical Research (DCR) of the Mass General Research Institute works to promote science at the clinical—research interface. The division sponsors a total of 9 centers and 10 units, each of which has a specific mission to assist investigators conducting clinical research.

Our mission is to increase the quality, quantity, and efficiency of translating basic science advances into improved care for our patients. Our researchers and clinicians partner with academia, industry, governments, foundations, and philanthropists to prevent and treat disease, and improve the lives of our patients.

There are two cornerstone initiatives of the Research Institute that fall under the Division of Clinical Research. The first is the Partners Biobank at MGH, where blood and DNA samples are collected from patients who have consented for these samples to be used in research.

These patients have also consented to be re-contacted to supply additional samples or information should a researcher request it. To date, over 100,000 samples have been collected; each of which are linked to the patient's electronic health record, and 20,000 of these have been genotyped.

The second cornerstone initiative of the DCR is the Translational Research Center. This center is a fully staffed 18-bed inpatient unit capable of bringing any preclinical therapeutic, device or diagnostic into first-in-human clinical trials, all the way through phase 2B trials. 

More Resources

  • For Patients: Team up with doctors and scientists at Mass General to speed the development of new medical treatments
  • For Researchers:  Study support, educational resources and consulting services to assist clinical research teams in every aspect of their studies
  • For Collaborators: Our clinical research is strengthened by partnerships with investigators from other academic institutions, as well as collaborators from foundations and industry